Last reviewed · How we verify
DCB-BO1301
At a glance
| Generic name | DCB-BO1301 |
|---|---|
| Sponsor | Chung Mei Biopharma Co., Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DCB-BO1301 CI brief — competitive landscape report
- DCB-BO1301 updates RSS · CI watch RSS
- Chung Mei Biopharma Co., Ltd portfolio CI